Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy.
Avolio PP, Fasulo V, Lughezzani G, Saitta C, Paciotti M, Gatti R, Russo F, Fantacci MV, Lazzeri M, Maffei D, Pasini L, Saita A, Hurle R, Casale P, Buffi NM. Avolio PP, et al. Among authors: fasulo v. Minerva Urol Nephrol. 2024 Jun;76(3):384-387. doi: 10.23736/S2724-6051.24.05848-8. Epub 2024 May 31. Minerva Urol Nephrol. 2024. PMID: 38819388 No abstract available.
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study.
Casale P, Saita A, Lazzeri M, Lughezzani G, Hurle R, Fasulo V, Mondellini GM, Paciotti M, Domanico L, Lista G, Maffei D, Monari M, Motta L, Bini V, Ceriotti F, Guazzoni G, Buffi NM. Casale P, et al. Among authors: fasulo v. Minerva Urol Nefrol. 2019 Jun;71(3):273-279. doi: 10.23736/S0393-2249.19.03279-X. Epub 2019 Jan 28. Minerva Urol Nefrol. 2019. PMID: 30700081 Free article.
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS.
Hurle R, Lazzeri M, Saita A, Naselli A, Guarneri A, Buffi NM, Lughezzani G, Fasulo V, Mondellini GM, Paciotti M, Domanico L, Peschechera R, Benetti A, Zandegiacomo S, Lista G, Pasini L, Guazzoni G, Casale P. Hurle R, et al. Among authors: fasulo v. Minerva Urol Nefrol. 2019 Aug;71(4):406-412. doi: 10.23736/S0393-2249.19.03254-5. Epub 2019 May 28. Minerva Urol Nefrol. 2019. PMID: 31144485 Free article.
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project.
Hurle R, Casale P, Saita A, Colombo P, Elefante GM, Lughezzani G, Fasulo V, Paciotti M, Domanico L, Bevilacqua G, Maffei D, Diana P, Frego N, Sandri MT, Maura F, Morenghi E, Buffi NM, Guazzoni G, Lazzeri M. Hurle R, et al. Among authors: fasulo v. World J Urol. 2020 Sep;38(9):2215-2220. doi: 10.1007/s00345-019-03002-3. Epub 2019 Nov 5. World J Urol. 2020. PMID: 31691083
67 results